Cargando…

Psychiatric symptoms caused by cannabis constituents: a systematic review and meta-analysis

BACKGROUND: Approximately 188 million people use cannabis yearly worldwide, and it has recently been legalised in 11 US states, Canada, and Uruguay for recreational use. The potential for increased cannabis use highlights the need to better understand its risks, including the acute induction of psyc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hindley, Guy, Beck, Katherine, Borgan, Faith, Ginestet, Cedric E, McCutcheon, Robert, Kleinloog, Daniel, Ganesh, Suhas, Radhakrishnan, Rajiv, D'Souza, Deepak Cyril, Howes, Oliver D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738353/ https://www.ncbi.nlm.nih.gov/pubmed/32197092 http://dx.doi.org/10.1016/S2215-0366(20)30074-2

Ejemplares similares

Association of Ketamine With Psychiatric Symptoms and Implications for Its Therapeutic Use and for Understanding Schizophrenia: A Systematic Review and Meta-analysis
por: Beck, Katherine, et al.
Publicado: (2020)

The effect of ketamine on psychopathology and implications for understanding schizophrenia and its therapeutic use: a meta-analysis
por: Beck, Katherine, et al.
Publicado: (2021)

The effects of cannabinoid 1 receptor compounds on memory: a meta-analysis and systematic review across species
por: Borgan, Faith, et al.
Publicado: (2019)

Gone to Pot – A Review of the Association between Cannabis and Psychosis
por: Radhakrishnan, Rajiv, et al.
Publicado: (2014)

Editorial: Gone to Pot: Examining the Association Between Cannabis Use and Medical/Psychiatric Disorders
por: Radhakrishnan, Rajiv, et al.
Publicado: (2022)

Glutamate levels in the anterior cingulate cortex in un-medicated first episode psychosis: a proton magnetic resonance spectroscopy study
por: Borgan, Faith R., et al.
Publicado: (2019)

N-Methyl-D-Aspartate Receptor binding in First-Episode Psychosis: A PET brain imaging study
por: Beck, Katherine, et al.
Publicado: (2021)

Cannabis and Driving
por: Pearlson, Godfrey D., et al.
Publicado: (2021)

Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis
por: Pillinger, Toby, et al.
Publicado: (2020)

Defining the Locus of Dopaminergic Dysfunction in Schizophrenia: A Meta-analysis and Test of the Mesolimbic Hypothesis
por: McCutcheon, Robert, et al.
Publicado: (2018)

Inflammation and the neural diathesis-stress hypothesis of schizophrenia: a reconceptualization
por: Howes, O D, et al.
Publicado: (2017)

The relationship between cortical glutamate and striatal dopamine in first-episode psychosis: a cross-sectional multimodal PET and magnetic resonance spectroscopy imaging study
por: Jauhar, Sameer, et al.
Publicado: (2018)

The effect of antipsychotics on glutamate levels in the anterior cingulate cortex and clinical response: A (1)H-MRS study in first-episode psychosis patients
por: Zahid, Uzma, et al.
Publicado: (2022)

Variability of glucose, insulin, and lipid disturbances in first-episode psychosis: a meta-analysis
por: Pillinger, Toby, et al.
Publicado: (2023)

The relationship between striatal dopamine and anterior cingulate glutamate in first episode psychosis changes with antipsychotic treatment
por: Jauhar, Sameer, et al.
Publicado: (2023)

F18. IS SCHIZOPHRENIA A MULTI-SYSTEM DISORDER? CONSIDERING NEUROLOGICAL, IMMUNE, CARDIOMETABOLIC, AND ENDOCRINE ALTERATIONS IN FIRST EPISODE PSYCHOSIS
por: Pillinger, Toby, et al.
Publicado: (2018)

Schizophrenia, Dopamine and the Striatum: From Biology to Symptoms
por: McCutcheon, Robert A., et al.
Publicado: (2019)

Is psychosis a multisystem disorder? A meta-review of central nervous system, immune, cardiometabolic, and endocrine alterations in first-episode psychosis and perspective on potential models
por: Pillinger, Toby, et al.
Publicado: (2018)

Correction to: Is psychosis a multisystem disorder? A meta-review of central nervous system, immune, cardiometabolic, and endocrine alterations in first-episode psychosis and perspective on potential models
por: Pillinger, Toby, et al.
Publicado: (2018)

N-methyl-D-aspartate receptor availability in first-episode psychosis: a PET-MR brain imaging study
por: Beck, Katherine, et al.
Publicado: (2021)

Comparative Effects of Antipsychotics on Metabolic and Endocrine Function in Children and Young People With Schizophrenia: A Systematic Review and Network Meta-Analysis
por: Rogdaki, Maria, et al.
Publicado: (2023)

Heterogeneity and efficacy of antipsychotic treatment for schizophrenia with or without treatment resistance: a meta-analysis
por: Mizuno, Yuya, et al.
Publicado: (2019)

Dopaminergic organization of striatum is linked to cortical activity and brain expression of genes associated with psychiatric illness
por: McCutcheon, Robert A., et al.
Publicado: (2021)

White-matter free-water diffusion MRI in schizophrenia: a systematic review and meta-analysis
por: Carreira Figueiredo, Inês, et al.
Publicado: (2022)

Differential Cognitive Performance in Females and Males with Regular Cannabis Use
por: Martin, Ashley M. Schnakenberg, et al.
Publicado: (2021)

Glutamate connectivity associations converge upon the salience network in schizophrenia and healthy controls
por: McCutcheon, Robert A., et al.
Publicado: (2021)

T79. BALANCING EFFECTS WITH SIDE-EFFECTS: EXAMINING COMPARATIVE METABOLIC CONSEQUENCES OF 18 ANTIPSYCHOTICS IN TREATMENT OF SCHIZOPHRENIA USING NETWORK META-ANALYSIS
por: Pillinger, Toby, et al.
Publicado: (2020)

Space and astronomy: the people behind the science
por: McCutcheon, Scott, et al.
Publicado: (2005)

Psychiatric Morbidity of Cannabis Abuse
por: Sarkar, Jaydip, et al.
Publicado: (2003)

Association between cannabinoid 1 receptor availability and glutamate levels in healthy controls and drug-free patients with first episode psychosis: a multi-modal PET and 1H-MRS study
por: Borgan, Faith, et al.
Publicado: (2020)

Antipsychotic plasma levels in the assessment of poor treatment response in schizophrenia
por: McCutcheon, R., et al.
Publicado: (2017)

Altered glutamatergic response and functional connectivity in treatment resistant schizophrenia: the effect of riluzole and therapeutic implications
por: Pillinger, Toby, et al.
Publicado: (2019)

Chronic psychosocial stressors are associated with alterations in salience processing and corticostriatal connectivity
por: McCutcheon, Robert A., et al.
Publicado: (2019)

S172. GLUTAMATE RELATED CONNECTIVITY DISTURBANCES OF THE SALIENCE AND DEFAULT MODE NETWORKS IN PSYCHOSIS
por: McCutcheon, Rob, et al.
Publicado: (2020)

A Meta-analysis of Immune Parameters, Variability, and Assessment of Modal Distribution in Psychosis and Test of the Immune Subgroup Hypothesis
por: Pillinger, Toby, et al.
Publicado: (2019)

F180. CANNABINOID 1 RECEPTOR AVAILABILITY & MEMORY FUNCTION IN FIRST EPISODE PSYCHOSIS: A MULTI-MODAL PET-FMRI STUDY
por: Borgan, Faith, et al.
Publicado: (2018)

The effects of psychosocial stress on dopaminergic function and the acute stress response
por: Bloomfield, Michael AP, et al.
Publicado: (2019)

Phytochemical Constituents and Derivatives of Cannabis sativa; Bridging the Gap in Melanoma Treatment
por: Schanknecht, Ellen, et al.
Publicado: (2023)

Neural Responsivity to Food Cues in Patients With Unmedicated First-Episode Psychosis
por: Borgan, Faith, et al.
Publicado: (2019)

Position statement of the Brazilian Psychiatric Association on the use of cannabis in psychiatric treatment
por: da Silva, Antônio Geraldo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fhjb4hnnra9po9ii5dll92mc48